Clinical pathologic and immunohistochemical analysis of 249 cases of exocrine pancreatic carcinoma

( views:, downloads: )
Author:
()
()
()
()
()
()
()
Journal Title:
CHINESE JOURNAL OF PANCREATOLOGY
Issue:
Volume 3, Issue 04, 2003
DOI:
Key Word:

Abstract:

  • [1]赵平.我国胰腺癌诊治策略的研究.胰腺病学,2002,2:193-195.
  • [2]Kloppel G, Adler G, Hruban RH, et al. Tumors of the exocrine pancreas in WHO classification of tumors: pathology and genetics of tumors of the digestive system. Lyon: IARC Press, 2000: 219-250.
  • [3]于观贞,朱明华,倪灿荣,等.应用组织芯片技术研究p33ING1在胰腺癌中的表达及意义.胰腺病学,2002,2:199-203.
  • [4]Lu CD, Altieri DC, Tanigawa N. Expression of a novel antiapoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas. Cancer Res, 1998, 58:1808-1812.
  • [5]陆星华.胰腺癌研究现状与展望.胰腺病学,2003,3:63-65.
  • [6]张群华,倪泉兴,张延龄.应加大胰腺癌诊治研究的力度.中华医学杂志,2002,82:361-362.
  • [7]Hirai I, Kimura W, Ozawa K, et al. Perineural invasion in pancreatic cancer. Pancreas, 2002, 24:15-25.
  • [8]Adsay NV, Pierson C, Sarkar F, et al. Colloid (mucinous noncystic) carcinoma of the pancreas. Am J Surg Pathol, 2001,25:26-42.
  • [9]于观贞,朱明华.胰腺癌的分子变化基础及分子诊断.国外医学.生理、病理科学与临床分册.2003,23:64-66.
  • [10]Gerdes B, Ramaswamy A, Ziegler A, et al. p16INK4a is a prognostic marker in resected ductal pancreatic cancer: an analysis of p16INK4a, p53, MDM2, and Rb. Ann Surg, 2002,235: 51-59.
  • [11]Inoue S, Tezel E, Nakao A. Molecular diagnosis of pancreatic cancer. Hepatogastroenterology, 2001, 48: 933-938.
  • [12]陈笑雷,张群华,倪泉兴.p14ARF和p53抑癌基因对胰腺癌生物学行为的影响.中华医学杂志,2003,83:868-871.
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn